EMERYVILLE, Calif., May 16, 2022 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that Ryan Spencer, Chief Executive Officer, will present at the H.C....
News Ticker
- [ June 28, 2022 ] Memorial Hermann and Helix Partner on a Population Genomics Initiative Aimed at Driving Precision Health Care for Texans News
- [ June 28, 2022 ] Curebase Hires HR Veteran Andi Seymour as VP of People News
- [ June 28, 2022 ] Telesair Secures Strategic OUS License Agreement for Next Generation Respiratory Technology News
- [ June 28, 2022 ] Investing in Clinical Evidence for Transparent AI, Fairtility to Present Five Orals and Seven Posters at ESHRE 2022 News
- [ June 28, 2022 ] City of South San Francisco Holds First Commission on Equity and Public Safety Meeting News
Copyright © 2022 Biotech Networks, LLC
